Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2020.616 | Effect of Substitution Rate on Solute Clearances for Patients Receiving Pre-dilution On-line Hemodiafiltration |
Dr. NG Sheung Wah 吳尚華 |
| 2023.297 | The Effectiveness of a Psycho-education Program in improving Stoma Care Self-efficacy and Health-related Quality of Life for Patient after Colorectal Cancer Surgery: A Randomized Controlled Trial | Ms. NG Shuk Ching |
| 2023.311 | A pilot study of efficacy and safety of a microbiome immunity formula (SIM05) in adults with atopic eczema |
Prof. NG Siew Chien 黃秀娟 |
| 2021.564 | Clinical outcomes and prognostic factors of Acute Severe Ulcerative Colitis (ASUC) in Asia | Prof. NG Siew Chien |
| 2022.308 | Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease | Prof. NG Siew Chien |
| 2022.310 | Faecal microbiota transplantation for post-acute COVID-19 syndrome: a pilot open-label study |
Prof. NG Siew Chien 黃秀娟教授 |
| 2022.266 | To characterise the symptoms and gut microbiome for Long COVID in recovered COVID-19 survivors |
Prof. NG Siew Chien 黃秀娟 |
| 2022.531 | The Bacteriome, Fungome, Virome, and Metabolome in families with Crohn's disease - A multicentered retrospective study |
Prof. NG Siew Chien 黃秀娟 |
| 2022.540 | National Mother-baby Birth Cohort Study: Microbiome Structure and Function |
Prof. NG Siew Chien 黃秀娟 |
| 2021.036 | Investigating the Gut Microbiota of Individuals with Adenoma, Advanced Adenoma and Colorectal Cancer | Prof. NG Siew Chien |
| 2021.264 | Exposomics for Early Life Crohn’s Disease |
Prof. NG Siew Chien 黃秀娟 |
| 2021.146 | Microbial stool biomarkers for prediction of Autism and ADHD in children |
Prof. NG Siew Chien 黃秀娟 |
| 2023.199 | A Prospective Study of Stool Microbial Biomarkers for Early Detection and Risk Prediction of Autism Spectrum Disorder (PROMISE) |
Prof. NG Siew Chien 黃秀娟 |
| 2021.088 | COVID-19, Mental Health and Inflammatory Bowel Disease: A population-based, prospective observational study of disease impact, mental health and patient resilience | Prof. NG Siew Chien |
| 2021.259 | A randomised-controlled trial of an oral microbiome immunity formula in reducing development of long-term co-morbidities in recovered COVID-19 patients (RECOVERY) |
Prof. NG Siew Chien 黃秀娟 |
| 2021.461 | A Chinese-specific low food additive diet in patients with mild-to-moderate Crohn’s disease – a pilot study | Prof NG Siew Chien |
| 2021.260 | Longitudinal assessment of gut microbiota profile and its impact on immunity status in COVID-19 vaccinated cohorts in Hong Kong |
Prof. NG Siew Chien 黃秀娟 |
| 2021.514 | Biobank for Microbiota Research (Biobank-Microbiota) |
Prof. NG Siew Chien 黃秀娟 |
| 2017.004 | Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis |
Prof. NG Siew Chien 黃秀娟 |
| 2014.370 | Functional Characterization and Regulation of Claudin-8: A Novel Regulator of Colonic Epithelial Barrier Function In Inflammatory Bowel Disease | Prof. NG Siew Chien |
| 2015.051 | ASSURANCE: Surveillance for Neoplasia in Inflammatory Bowel Disease | Prof. NG Siew Chien |
| 2015.471 | A Randomized, Double-Blind, Double-Dummy, Multicenter, Active-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab IV Compared to Adalimumab SC in Subjects With Ulcerative Colitis |
Prof. NG Siew Chien 黃秀娟 |
| 2015.145 | A prospective colonoscopic study to investigate risk of colorectal neoplasms in first-degree relatives of patients with non-advanced adenomas | Prof. NG Siew Chien |
| 2017.260 | The Fecal Microbiota Transplantation Registry (FMTR) |
Prof. NG Siew Chien 黃秀娟教授 |
| 2017.379 | A Pilot Study of Fecal Microbiota Transplant (FMT) and Its Effects in Patients with Crohn’s Disease with Moderate-to-High Risk of Colonization of Adherent-Invasive E. Coli (AIEC) |
Prof. NG Siew Chien 黃秀娟教授 |
| 2015.478 | An Epidemiological Study on the Prevalence of Gastrointestinal Diseases Over a 10-year Period for All Public Hospitals in Hong Kong from 2005 to 2014 |
Prof. NG Siew Chien 黄秀娟 |
| 2015.453 | Fecal Microbiota Transplantation (FMT) for active Ulcerative Colitis (UC) with Concurrent Stool Microbiota Assessment (FMT-UC Study) | Prof. NG Siew Chien |
| 2015.454 | Fecal Microbiota Transplantation (FMT) for Recurrent and Refractory Clostridium Difficile Infection (CDI) with Concurrent Stool Microbiota Assessment (FMT-RCDI) Study | Prof. NG Siew Chien |
| 2015.527 | A Randomised, Placebo-controlled Study on Fecal Microbiota Transplantation for Patients with Irritable Bowel Syndrome with Fecal and Mucosal Microbiota Assessment |
Prof. NG Siew Chien 黃秀娟 |
| 2016.629 | Continuation of warfarin and the risk of colonoscopic polypectomy bleeding: A double-blind, randomized, placebo-controlled trial |
Prof. NG Siew Chien 黃秀娟教授 |
| 2015.528 | A Combined Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluating the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis |
Prof. NG Siew Chien 黃秀娟教授 |
| 2015.575 | A Double-blind, Randomized, Placebo-Controlled Trial of Curcumin versus Placebo for Prevention of Relapse in Patients with Ulcerative Colitis |
Prof. NG Siew Chien 黃秀娟 |
| 2016.407 | Gut Microbiota of Patients with IBD Living In Rural and Urban Area |
Prof. NG Siew Chien 黃秀娟 |
| 2017.495 | The ENIGMA II Study: Eastern Inflammatory Bowel Disease Gut Microbiota |
Prof. NG Siew Chien 黃秀娟教授 |
| 2018.070 | When should low-dose aspirin be resumed after peptic ulcer bleeding? A randomized controlled trial |
Prof. NG Siew Chien 黃秀娟教授 |
| 2014.459 | A randomized, controlled trial of the discontinuation of a standard maintenance therapy of oral aminosalicylic acid in ulcerative colitis patients in long-term remission | Prof Ng Siew Chien |
| 2016.136 | A randomised placebo-controlled study of fecal microbiota transplant (FMT) to impact body weight and glycemic control in obese subjects with type 2 diabetes mellitus | Prof. NG Siew Chien |
| 2016.033 | Development of donor screening and systematic stool bank for Fecal Microbiota Transplantation (Stool bank study) | Prof. NG Siew Chien |
| 2016.135 | The impact of fecal microbiota transplant (FMT) to body weight and glycemic control in obese subjects with type 2 diabetes mellitus | Prof. NG Siew Chien |
| 2015.601 | Knowledge and Attitudes towards pregnancy in women with Inflammatory Bowel Disease |
Prof. NG Siew Chien 黃秀娟 |
| 2016.547 | A prospective study of pregnant women with and without IBD in order to better understand the patterns of bacterial transmission from the mother to the baby. |
Prof. NG Siew Chien 黃秀娟教授 |
| 2014.183 | Fecal Microbiota Transplantation (FMT) for Moderate to Severe Clostridium Difficile Infection (CDI): A Randomised Study with Concurrent Stool Microbiota Assessment | Prof. NG Siew Chien |
| 2024.158 | Faecal microbiota transplantation for insomnia disorder: a randomized, double-blind, placebo-controlled trial |
Prof. NG Siew Chien 黃秀娟 |
| 2011.598 | A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission with GSK1605786A in Subjects with Moderately-to-Severely Active Crohn | Dr Ng Siew Chien |
| 2011.597 | A 52 week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects with Crohn's Disease | Dr Ng Siew Chien |
| 2010.190 | Manipulation of Visceral Hypersensitivity with Probiotic Bacteria in Irritable Bowel Syndrome (IBS Probiotic Study) | Dr Ng Siew Chien |
| 2013.362 | Curcumin Add-on Therapy for Induction of Remission in Mild-to-Moderate Ulcerative Colitis: A Prospective, Randomized, Placebo-Controlled, Double-Blind Study | Prof Ng Siew Chien |
| 2014.113 | Identification and Characterization of the Gut Microbiota in Incident Inflammatory Bowel Disease Individuals from a Population-based Cohort | Prof NG Siew Chien |
| 2014.053 | Oral 5-aminosalicyclic Acid Withdrawal in Long Standing Inactive Ulcerative Colitis: A Double-blind, Randomized, Placebo-controlled Trial | Prof. NG Siew Chien |
| 2011.528 | Chief Project Title: The Role of Interferon Gamma Releasing Assays (IGRA) in Screening and Monitoring for Tuberculosis during Anti-TNF therapy in Patients with Immune-mediated Inflammatory Disease (IMID) Sub-study 1: To evaluate the IGRA status of IBD patients receiving anti-TNF therapy or other immunosuppressive drugs Sub-Study 2: A prospective study of serial interferon-gamma release assays (IGRA) for the diagnosis of tuberculosis (TB) infection in patients with immune-mediated inflammatory diseases (IMID) treated with biologics Sub-Study 3: A retrospective study on the rate of tuberculosis infection in patients treated with biologics | Prof. NG Siew Chien |
Page 180 of 262.